•Not only does Optime appear to be a captured specialty pharmacy, deriving most if not substantially all of its revenues from Corcept, but when we called Optime, its representative told us over a recorded phone call that Corcept and Optime were one and the same. We were then transferred to a second representative, introduced as a specialty pharmacy care coordinator, who reiterated that we had reached Corcept. We placed a recording of the call on YouTube (here) for any interested investor to listen. We believe, based on this evidence, that Corcept’s sole specialty pharmacy and exclusive distributor is an undisclosed related party. If Optime’s employees believe that Corcept and Optime are one and the same, then it creates the material risk that the Company is using its captured pharmacy to boost sales, hide losses or engage in other financial shenanigans. We can’t know for sure because Optime’s financials are not publicly available.